Bi-Specific antibody, antithrombin and other new developments

Written by 

 

 

 

 



Johannes Oldenburg

Prof. Dr. med. Johannes Bernhard Oldenburg (MD, PhD):

Johannes Oldenburg is Professor and Director of the Institute of Experimental Haematology and Transfusion Medicine and the Haemophilia Center, University Clinic Bonn, Germany. Since 1995, his research has focused on molecular genetics of blood coagulation factors (focus in haemophilia), vitamin K pathway (discovery of VKORC1, the target of Cumarins) and he has published more than 350 articles in these fields.

Prof. Oldenburg has received various scientific awards including the GEFFRUP-Award University Clinic Bonn (1992), Johann Lukas Schönlein Award (1996), Research-Award of the German Society of Thrombosis and Haemostasis Research (GTH) (1998), Alexander Schmidt Award of the GTH (2002) and more.

Prof. Oldenburg is a reviewer for several Journals in the field of Haemostasis, Genetics and Pharmacogenetics and currently sits or has participated on the Editorial Boards of Blood, Journal of Thrombosis and Haemostasis, Thrombosis and Haemostasis, Haematologica, Haemophilia, Annals of Hematology, Blood Coagulation and Fibrinolysis

Prof. Oldenburg is a Member of the Arbeitskreis Blut, German Health Ministry and was Co-Chairman of the Scientific Subcommittee on Factor VIII & IX of the ISTH. He is a member of the International Society of Thrombosis and Haemostasis (ISTH), American Society of Hematology (ASH), German Societies of Thrombosis and Haemostasis Research (GTH), German Society of Transfusion Medicine and Immunohaematology (DGTI), International Society of Blood Transfusion (ISBT), Society of Human Genetics (GfH), and European Association for Haemophilia and Allied Disorders (EAHAD).

Video

Please log in to see video
Rate this item
(0 votes)
Login to post comments